IASLC Announces Partnerships to Spur Oncogene-Driven Lung Cancer Research, Address Global Challenges in Conquering Thoracic Cancers
Erin JungmeyerThe initiatives include a $2.5 million, 4-year research grant and projects to improve lung cancer biomarker testing uptake around the world. Read more
The association recommends collecting data on tobacco use status to advance knowledge on the impacts of tobacco smoke in the context of cancer clinical trials. Read more
Dr. Jennifer King brings expertise in molecular targets for cancer therapeutics as well as executive-level experience implementing strategic initiatives to the scientific affairs team. Read more
Editor-in-Chief Dr. Alex Adjei announced the journal’s impact factor once again rose in 2022 and says it remains the leading journal in thoracic oncology. Read more
The newly elected board members, including President-Elect Dr. Caicun Zhou, will assume their roles at the upcoming 2023 World Conference on Lung Cancer in Singapore. Read more
Histologic Evaluation of Lung Cancer Invasion: More Difficult Than Meets the Eye
Mary Beth Beasley, MD+more
IASLC Pathology Committee members say the identification and evaluation of features that result in discordance in measuring invasive tumor size will hopefully improve reproducibility and lead to more accurate tumor staging moving forward. Read more
IASLC Staging Project Finalizing Recommendations for 9th Edition of TNM Classification System
Erin JungmeyerIn a recent interview, Staging and Prognostic Factors Committee Chair Dr. Hisao Asamura provides an update on efforts to further refine the system. Read more
In a Q&A with ILCN, new JTO Clinical and Research Reports Editor-in-Chief Dr. Emily Stone discusses her passion for tobacco control and the importance of open-access journals in elevating research globally. Read more
IASLC is now accepting abstract submissions for WCLC 2023 and nominations for committee membership and leadership. Read more
Committee Update: Advocates Offer Unique Support to Members, Help Investigators Understand Patients
Erin JungmeyerPatient Advocates Committee Chair Jill Feldman said ensuring the patient voice is present in research helps to improve the work being done to reduce the burden of lung cancer worldwide. Read more